Skip to content

Sepsis Multiomic Analysis & Risk sTratification in China(China SMART-1)

Sepsis Multiomic Analysis & Risk sTratification in China(China SMART-1)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126421
Enrollment
Unknown
Registered
2026-06-09
Start date
2026-06-20
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Sponsors

Yuebei People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Sepsis: (1) Age > 18 years; (2) Meet the Sepsis-3 diagnostic criteria for sepsis: confirmed or suspected infection with an increase in SOFA score (Sequential Organ Failure Assessment) of >= 2 points from baseline; (3) Develop sepsis within 72 hours of ICU admission; (4) Voluntarily sign the informed consent form (or signed by the legal representative). 2. Non-sepsis: (1) Age > 18 years; (2) No clear evidence of infection and not meeting the diagnostic criteria for sepsis; (3) Expected ICU treatment time >= 24 hours; (4) Voluntarily sign the informed consent form (or signed by the legal representative).

Exclusion criteria

Exclusion criteria: 1.Complicated with end-stage chronic organ failure (end-stage renal disease, decompensated liver cirrhosis (Child-Pugh Grade C), chronic heart failure NYHA Class IV), or malignant tumor; 2.Immunocompromised or suffering from autoimmune diseases, or long-term use of glucocorticoids/immunosuppressants within the past 3 months; 3.Pregnant and postpartum patients; 4.Patients with incomplete data collection; 5.Other conditions deemed unsuitable for participation in the study by the investigator (such as terminal state, refusal to cooperate with sample collection, or inability to cooperate with in-hospital and out-of-hospital follow-up).

Design outcomes

Primary

MeasureTime frame
Molecular Risk Stratification of Sepsis;Diagnostic performance: AUC, sensitivity, specificity, positive/negative predictive value;Core diagnostic markers of whole-genome mRNA expression profiles;

Countries

China

Contacts

Public ContactZhao Pingsen

Yuebei People’s Hospital

zhaopingsen01@163.com+86 133 3287 6639

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026